The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Single-agent LV305 to induce anti-tumor immune and clinical responses in patients with advanced or metastatic sarcoma and other cancers expressing NY-ESO-1.
 
Neeta Somaiah
Honoraria - Immune Design
Travel, Accommodations, Expenses - Immune Design
 
Matthew Stephen Block
Research Funding - Immune Design; TapImmune Inc.
 
Joseph W. Kim
Consulting or Advisory Role - Dendreon
Research Funding - Immune Design
 
Geoffrey Shapiro
Consulting or Advisory Role - Chugai Pharma; EMD Serono; G1 Therapeutics; Lilly; Takeda; Tesaro; Vertex
Research Funding - Aileron Therapeutics (Inst); AstraZeneca (Inst); Bayer (Inst); Cellceutix (Inst); Covidien (Inst); Cyclacel (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Immune Design (Inst); Lilly; Millennium (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); PTC Therapeutics (Inst); Puma Biotechnology (Inst); Sanofi (Inst); Tensha Therapeutics (Inst); Vertex (Inst)
 
Khanh Tu Do
No Relationships to Disclose
 
Patrick Hwu
Stock and Other Ownership Interests - immatics; Lion Biotechnologies
Consulting or Advisory Role - Lion Biotechnologies
Research Funding - Bristol-Myers Squibb (Inst); Genentech (Inst)
 
Joseph Paul Eder
Honoraria - Merck
 
Robin Lewis Jones
Honoraria - Compass Oncology; EMD Serono; IMS Health; Novartis; Pfizer; The Dominion Group
Consulting or Advisory Role - Compass Oncology; EMD Serono; IMS Health; Novartis; Pfizer; The Dominion Group
Research Funding - Bayer (Inst); Eisai (Inst); GlaxoSmithKline (Inst); ImClone Systems (Inst); Infinity Pharmaceuticals (Inst); Janssen Research & Development (Inst); MabVax (Inst); Merck Sharp & Dohme (Inst); Morphotek (Inst); Novartis (Inst); PharmaMar (Inst); Threshold Pharmaceuticals (Inst); Ziopharm Oncology (Inst)
Travel, Accommodations, Expenses - Compass Oncology; EMD Serono; Novartis; Pfizer; PharmaMar
 
Sacha Gnjatic
Consulting or Advisory Role - Third Rock Ventures
Research Funding - Immune Design; Janssen Research & Development
Patents, Royalties, Other Intellectual Property - Patents on NY-ESO-1 immune compositions and peptides.
 
Hailing Lu
Employment - Immune Design
Stock and Other Ownership Interests - Immune Design
 
Jan Ter Meulen
Employment - Immune Design
Leadership - Immune Design
Stock and Other Ownership Interests - Immune Design; Merck
Travel, Accommodations, Expenses - Immune Design
 
Frank J. Hsu
Employment - Immune Design
Leadership - Immune Design
Stock and Other Ownership Interests - Genzyme; Immune Design; Zyngenia
Patents, Royalties, Other Intellectual Property - Genzyme; immune Design; Stanford University
Travel, Accommodations, Expenses - Immune Design
 
Seth Pollack
No Relationships to Disclose